Skip to main content

Table 3 The counts and immunological profiles of mature DCs (A) and activatedT cell (B) in MASCT

From: Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy

 

Total counts (×109)

HLA-DR+ (%)

CD80+ (%)

CD86+ (%)

CD83+ (%)

  

A

  

 Mean ± SD

2.23 ± 1.21

90.85 ± 8.19

88.97 ± 15.60

89.35 ± 11.29

67.91 ± 20.52

  
 

Total counts (×109)

CD3+ (%)

CD8+ (%)

CD4+ (%)

CD3+CD56+ (%)

CD8+CD107a+ (%)

Tregs (%)

B

 Mean ± SD

6.63 ± 2.11

92.7 ± 5.26

56.5 ± 16.90

29.28 + 16.16

13.63 ± 12.60

50.31 ± 16.28

0.10 ± 0.20

  1. The regulatory T cells (Tregs) were defined as CD4+CD25+FoxP3+ expression